Another finding in the current study that supports the therapeutic effect of β-OHB in both AD and atherosclerosis is that β-OHB reduced the serum level of resistin, a hormone that plays important roles in, and is associated with, both AD [35] and atherosclerosis [36]. Here, RETN is linked to atherosclerosis.